Annette Vu

660 total citations
9 papers, 503 citations indexed

About

Annette Vu is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Annette Vu has authored 9 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Annette Vu's work include Neuroblastoma Research and Treatments (9 papers), Cell death mechanisms and regulation (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Annette Vu is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Cell death mechanisms and regulation (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Annette Vu collaborates with scholars based in United States, Australia and United Kingdom. Annette Vu's co-authors include Michael D. Hogarty, Xueyuan Liu, David R. Wise, M. Celeste Simon, Guoliang Qing, Zandra E. Walton, John M. Maris, Bo Li, Patrick A. Mayes and Nicolas Skuli and has published in prestigious journals such as The EMBO Journal, Cancer Cell and Cancer Research.

In The Last Decade

Annette Vu

8 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annette Vu United States	6	377	219	120	75	64	9	503
Crystal G. Wheeler United States	11	404 1.1×	97 0.4×	47 0.4×	58 0.8×	66 1.0×	15	557
Laura Di Magno Italy	15	506 1.3×	77 0.4×	25 0.2×	106 1.4×	21 0.3×	22	620
Ami Albihn Sweden	8	323 0.9×	83 0.4×	67 0.6×	127 1.7×	38 0.6×	8	426
Liangqian Huang China	9	268 0.7×	135 0.6×	21 0.2×	70 0.9×	38 0.6×	9	346
BaoHan T. Vo United States	12	335 0.9×	107 0.5×	23 0.2×	114 1.5×	38 0.6×	15	502
Anna Kock Sweden	8	110 0.3×	100 0.5×	99 0.8×	88 1.2×	14 0.2×	11	313
Srikumar Chellappan United States	7	412 1.1×	139 0.6×	10 0.1×	129 1.7×	71 1.1×	10	556
Ajoy Kumar Samraj Germany	11	263 0.7×	38 0.2×	39 0.3×	51 0.7×	24 0.4×	12	408
Michael D. Brewer United States	5	370 1.0×	130 0.6×	8 0.1×	110 1.5×	71 1.1×	5	478
Meryem Koese Australia	6	271 0.7×	86 0.4×	29 0.2×	36 0.5×	51 0.8×	6	331

Countries citing papers authored by Annette Vu

Since Specialization

Citations

This map shows the geographic impact of Annette Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Vu more than expected).

Fields of papers citing papers by Annette Vu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Vu. The network helps show where Annette Vu may publish in the future.

Co-authorship network of co-authors of Annette Vu

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Vu. A scholar is included among the top collaborators of Annette Vu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Vu. Annette Vu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Franson, Andrea, Kangning Liu, Elizabeth W. Scadden, et al.. (2025). High-dose DFMO alters protein translation in neuroblastoma. Neoplasia. 68. 101215–101215.

2.

Çoku, Jorida, David M. Booth, J. Škoda, et al.. (2022). Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance. The EMBO Journal. 41(8). e108272–e108272. 23 indexed citations

3.

McNerney, Kevin O., Spyridon Karageorgos, Chakkapong Burudpakdee, et al.. (2022). TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy. OncoImmunology. 11(1). 2075204–2075204. 11 indexed citations

4.

Shen, Shuang, et al.. (2019). Modulation of anti-tumour activity of ex vivo expanded NK and GD2CAR-NK cells against neuroblastoma. Cytotherapy. 21(5). S20–S20. 4 indexed citations

5.

Chen, Lindi, et al.. (2018). Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours. International Journal of Oncology. 52(3). 967–977. 3 indexed citations

6.

Evageliou, Nicholas F., Michelle Haber, Annette Vu, et al.. (2016). Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression. Clinical Cancer Research. 22(17). 4391–4404. 64 indexed citations

7.

Laetsch, Theodore W., et al.. (2014). Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma. Cell Death and Disease. 5(2). e1072–e1072. 33 indexed citations

8.

Goldsmith, Kelly C., Xueyuan Liu, Annette Vu, et al.. (2012). Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma. Cancer Research. 72(10). 2565–2577. 62 indexed citations

9.

Qing, Guoliang, Bo Li, Annette Vu, et al.. (2012). ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation. Cancer Cell. 22(5). 631–644. 303 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact